Atlanta Consulting Group Advisors, LLC Astrazeneca PLC Transaction History

Atlanta Consulting Group Advisors, LLC

  • $270 Billion
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024
BUY
$76.67 - $87.62 $200,722 - $229,389
2,618 New
2,618 $204 Million
Q1 2024

Aug 26, 2024
BUY
$61.03 - $69.57 $202,375 - $230,694
3,316 New
3,316 $225 Million
Q1 2024

May 13, 2024
BUY
$61.03 - $69.57 $202,375 - $230,694
3,316 New
3,316 $225 Million

Others Institutions Holding AZN

# of Institutions
1,368
Shares Held
475M
Call Options Held
6.08M
Put Options Held
4.44M
View Full List

About ASTRAZENECA PLC

AZN Quotes by TradingView
  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $230B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Atlanta Consulting Group Advisors, LLC Portfolio

Follow Atlanta Consulting Group Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atlanta Consulting Group Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Atlanta Consulting Group Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email